ROCKVILLE, Md., March 29, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China, U.S., and throughout the world, today reported...
from PR Newswire: https://ift.tt/2CJJKgS
No comments:
Post a Comment